← ANALYST RATINGS · TIPRANKS
Clarivate (CLVT): analyst forecast and price target
Analyst consensus
Hold1 Buy3 Hold1 Sell
Ratings of 5 analysts in the last 3 months12-month forecast
Based on 5 price targets given in the last 3 months, the average target is $3.02, the highest $5.00, the lowest $2.00. The average is +70.6% from the last price of $1.77.
Analyst ratings 7
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Information Technology ServicesxAI Grok-4 | TipRanks - xAI | $1.50 → $2.00+33.3% | Hold | +13.0% | Reiterated | 17.10.26on TipRanks 14:05 | — | |
| AI DeepSeek Information Technology ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $1.50 → $2.00+33.3% | Hold | +13.0% | Reiterated | 17.10.26on TipRanks 14:05 | — | |
| AI OpenAI Information Technology ServicesOpenAI 5.2 | TipRanks - OpenAI | $1.50 → $2.00+33.3% | Hold | +13.0% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI Google Information Technology ServicesGemini 3.1Pro | TipRanks - Google | $1.50 → $2.00+33.3% | Hold | +13.0% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI PerPlexity Information Technology ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $1.50 → $2.00+33.3% | Hold | +13.0% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI xAi Information Technology ServicesxAI Grok-4 | TipRanks - xAI | $2.00 → $1.50−25.0% | Hold | −15.3% | Reiterated | 30.09.26on TipRanks 08:05 | — | |
| AI DeepSeek Information Technology ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $2.00 → $1.50−25.0% | Hold | −15.3% | Reiterated | 30.09.26on TipRanks 08:05 | — | |
| AI OpenAI Information Technology ServicesOpenAI 5.2 | TipRanks - OpenAI | $2.00 → $1.50−25.0% | Hold | −15.3% | Reiterated | 30.09.26on TipRanks 08:05 | — | |
| AI Anthropic Information Technology ServicesAnthropic Opus-4.6 | TipRanks - Anthropic | $2.00 → $1.50−25.0% | Hold | −15.3% | Upgrade | 30.09.26on TipRanks 08:05 | — | |
| AI Google Information Technology ServicesGemini 3.1Pro | TipRanks - Google | $2.00 → $1.50−25.0% | Hold | −15.3% | Reiterated | 30.09.26on TipRanks 08:05 | — | |
| AI PerPlexity Information Technology ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $2.00 → $1.50−25.0% | Hold | −15.3% | Reiterated | 30.09.26on TipRanks 08:05 | — | |
| Shlomo Rosenbaum★★★★★★★★★★#2540 · hits 54% · avg +4.7% | Stifel Nicolaus | $6.00 → $5.00−16.7% | Buy | +182.5% | Assigned | 30.07.26on TipRanks 07:25 | −8.2%next day −2.2% · 5 days −11.6% | ↗ |
| Ashish Sabadra★★★★★★★★★★#6262 · hits 53% · avg +0.6% | RBC Capital | $3.00 | Hold | +69.5% | Reiterated | 30.07.26on TipRanks 07:25 | −8.2%next day −2.2% · 5 days −11.6% | ↗ |
| Peter Christiansen★★★★★★★★★★#10530 · hits 48% · avg −1.5% | Citi | $2.80 → $2.50−10.7% | Hold | +41.2% | Reiterated | 30.07.26on TipRanks 07:11 | −8.2%next day −2.2% · 5 days −11.6% | ↗ |
| George Tong★★★★★★★★★★#2673 · hits 55% · avg +3.9% | Goldman Sachs | $2.90 → $2.60−10.3% | Hold | +46.9% | Reiterated | 30.07.26on TipRanks 06:15 | −8.2%next day −2.2% · 5 days −11.6% | ↗ |
| Manav Patnaik★★★★★★★★★★#4393 · hits 56% · avg +1.6% | Barclays | $2.50 → $2.00−20.0% | Sell | +13.0% | Reiterated | 30.07.26on TipRanks 05:44 | −8.2%next day −2.2% · 5 days −11.6% | ↗ |
| Unknown Analyst | Jefferies | $2.50 | Hold | +41.2% | Reiterated | 07.07.26on TipRanks Jul 14 21:02 | +3.3%next day −11.6% · 5 days −8.1% | ↗ |
| Toni Kaplan★★★★★★★★★★#6771 · hits 53% · avg +0.5% | Morgan Stanley | $5.00 → $3.00−40.0% | Sell | +69.5% | Downgrade | 17.12.25on TipRanks 05:10 | +0.3%next day −3.9% · 5 days −6.8% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Clarivate
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $2.93 at a price of $1.67 (+75.6%); now: $3.02 at $1.77 (+70.6%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 4 | 7 | 6 | 6 | 0 |
| Sell | 2 | 2 | 2 | 2 | 2 | 0 |
Earnings and sales forecast
Next report: 03.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.18 (from $0.16 to $0.21). Last quarter: $0.19.
Sales
Next quarter’s sales estimate — $567M (from $490M to $586M). Last quarter: $587M.
Best top-analyst consensus in the sector · Technology
About Clarivate
- CEO: Matitiahu Shem Tov
- Employees: 12,000
- 70 St. Mary Axe, London, GL, EC3A 8BE, GB
- www.clarivate.com
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to C
Data from the stock’s TipRanks forecast page, read 71 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗